Advertisement
< Advance Online Publication

Risk stratification for benign prostatic hyperplasia

Risk stratification for benign prostatic hyperplasia

In press - Corrected proof

Article Type: REVIEW

DOI:10.5301/uro.5000220

Authors

Fabio Zattoni, Vincenzo Ficarra, Giacomo Novara

Abstract

Benign prostatic hyperplasia (BPH) represents an important public health problem in ageing men due to frequently associated lower urinary tract symptoms (LUTS), which may impair quality of life. BPH is also a progressive disease, mainly characterized by a worsening of LUTS over time, and in some patients by the occurrence of serious outcomes such as acute urinary retention and need for BPH-related surgery. The management of BPH and LUTS in men should move forward its focus on symptom control only. Indeed, the goals of therapy for BPH are not only to improve bothersome LUTS but also to identify those patients at risk of unfavourable outcomes in order to optimize their management and reduce complications. Risk stratification and tailored treatment should improve the reductions in both symptoms and the long-term consequences of BPH and BPH treatments. To do this, clinicians need to know possible factors that may support the develop of PBH and possible risks due to the BPH itself.

Article History

  • • Accepted on 03/02/2017
  • • Available online on 18/03/2017

Disclosures

Financial support: The authors do not report any funding for this study.
Conflict of interest: No potential conflict of interest relevant to this article was reported.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

Affiliations

  • Academic Medical Centre Hospital Santa Maria della Misericordia, Udine - Italy
  • Department of Experimental and Clinic Medical Sciences, Urology Unit, University of Udine, Udine - Italy
  • Department of Surgical and Gastrointestinal Sciences, Urologic Unit, University of Padua, Padua - Italy

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.